Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Expensify (EXFY) Gains from Investment Securities (2020 - 2025)

Expensify (EXFY) has disclosed Gains from Investment Securities for 6 consecutive years, with -$4.7 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 204.95% to -$4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.6 million through Dec 2025, down 457.04% year-over-year, with the annual reading at $135000.0 for FY2025, 93.8% down from the prior year.
  • Gains from Investment Securities hit -$4.7 million in Q4 2025 for Expensify, down from $584000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.9 million in Q4 2023 to a low of -$4.7 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged $77200.0 across 5 years, with a median of $293500.0 in 2022.
  • Biggest five-year swings in Gains from Investment Securities: crashed 1384.62% in 2021 and later surged 14650.0% in 2024.
  • Year by year, Gains from Investment Securities stood at -$579000.0 in 2021, then tumbled by 74.78% to -$1.0 million in 2022, then soared by 387.65% to $2.9 million in 2023, then plummeted by 153.45% to -$1.6 million in 2024, then tumbled by 204.95% to -$4.7 million in 2025.
  • Business Quant data shows Gains from Investment Securities for EXFY at -$4.7 million in Q4 2025, $584000.0 in Q3 2025, and $536000.0 in Q2 2025.